Use this URL to cite or link to this record in EThOS: https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.746327
Title: The role of invariant Natural Killer T cells in SLE patients with atherosclerosis
Author: Smith, E. C.
Awarding Body: UCL (University College London)
Current Institution: University College London (University of London)
Date of Award: 2016
Availability of Full Text:
Access from EThOS:
Full text unavailable from EThOS. Please try the link below.
Access from Institution:
Abstract:
Accelerated atherosclerosis is a complication of the rheumatic disease systemic lupus erythematosus (SLE). I questioned the role of invariant Natural Killer T (iNKT) cells in this process, since they are known to be defective in SLE but also promote atherosclerosis in response to CD1d-mediated lipid presentation. SLE patients with asymptomatic plaque (SLE-P) had an altered iNKT cell phenotype to those without plaque (SLE-NP), characterised by differences in activation marker expression and increased IL-4. This SLE-P iNKT cell phenotype correlated with differences in serum lipids including VLDL and coud be recapitulated in vitro by culturing healthy PBMCs with serum from SLE-P patients, an effect that was inhibited in the presence of anti-CD1d. Whilst differences in CD1d and lipid raft co-localisation and recycling were found in SLE patients, no difference was observed between SLE-NP and SLE-P patients. Isolation of phospholipids from SLE-P patients confirmed that differences in the lipids being presented were driving the anti-inflammatory iNKT cell phenotype in SLE-P patients. The finding that healthy iNKT cells, differentiated in the presence of healthy monocytes and serum from SLE-P patients, could induce THP-1 macrophage polarisation towards an anti-inflammatory M2-like phenotype suggested a protective role for iNKT cells in SLE patients with subclinical atherosclerosis. This was confirmed by studying a group of SLE patients who had suffered a cardiovascular event, where this protective iNKT cell phenotype seen in asymptomatic patients was lost.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.746327  DOI: Not available
Share: